(Q43037738)

English

Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection (English)

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Miyatake H

1

1 reference

Europe PubMed Central

12 November 2017

Kanto T

2

1 reference

Europe PubMed Central

12 November 2017

Inoue M

3

1 reference

Europe PubMed Central

12 November 2017

Sakakibara M

4

1 reference

Europe PubMed Central

12 November 2017

Kaimori A

5

1 reference

Europe PubMed Central

12 November 2017

Yakushijin T

6

1 reference

Europe PubMed Central

12 November 2017

Itose I

7

1 reference

Europe PubMed Central

12 November 2017

Miyazaki M

8

1 reference

Europe PubMed Central

12 November 2017

Kuzushita N

9

1 reference

Europe PubMed Central

12 November 2017

Hiramatsu N

10

1 reference

Europe PubMed Central

12 November 2017

Takehara T

11

1 reference

Europe PubMed Central

12 November 2017

Kasahara A

12

1 reference

Europe PubMed Central

12 November 2017

Hayashi N

13

1 reference

Europe PubMed Central

12 November 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

12 November 2017

14

1 reference

Europe PubMed Central

12 November 2017

404-412

1 reference

Europe PubMed Central

12 November 2017

6

1 reference

Europe PubMed Central

12 November 2017

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Natural history of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Kinetics of the immune response during HBV and HCV infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Antigen presentation and T cell stimulation by dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Pharmacokinetics of natural human IFN-alpha in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Impact of alpha interferon and ribavirin on the function of maturing dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Regulatory activity of autocrine IL-10 on dendritic cell functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00814.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2006.00814.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037738&oldid=1978290871"